Cancer Checkpoint Roundup: Big Pharmas Advance Ahead of ASCO
Executive Summary
During first-quarter earnings calls and ahead of the upcoming American Society of Clinical Oncology meeting, big pharma execs stressed the importance of developing immunotherapies in a range of cancers and highlighted the progress made so far.